Catalog No.
YVV19208
Expression system
E. coli
Species
Coxsackievirus A16 (strain G-10)
Protein length
Gly566-Leu862
Predicted molecular weight
35.20 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Q65900
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Capsid protein VP1, P1D, Virion protein 1
ZYG11B suppresses multiple enteroviruses by triggering viral VP1 degradation., PMID:40135890
Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16., PMID:35964922
Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils., PMID:35787233
Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection., PMID:34116877
SAMHD1 Inhibits Multiple Enteroviruses by Interfering with the Interaction between VP1 and VP2 Proteins., PMID:33883225
A Bacillus-based Coxsackie virus A16 mucosal vaccine induces strong neutralizing antibody responses., PMID:31114430
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge., PMID:30735461
Molecular characteristics of hand, foot, and mouth disease for hospitalized pediatric patients in Yunnan, China., PMID:30075535
Non-neutralizing Antibody Responses against VP1 in Enterovirus A, B, C and Rhinovirus A species among Infants and Children in Shanghai., PMID:29615683
Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2)., PMID:29356992
Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice., PMID:29129453
A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice., PMID:27771182
Virus-Like Particles Produced in Pichia Pastoris Induce Protective Immune Responses Against Coxsackievirus A16 in Mice., PMID:27659054
Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific., PMID:27622652
Study of the epidemiology and etiological characteristics of hand, foot, and mouth disease in Suzhou City, East China, 2011-2014., PMID:27146138
Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals., PMID:26917423
Protein microarray-mediated detection of antienterovirus antibodies in serum., PMID:26831405
A real-time RT-PCR assay for rapid detection of coxsackievirus A10., PMID:26782393
Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71., PMID:26296491
A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71., PMID:26243660
[Hand-foot-mouth disease pathogen separation and EV71 VP1 gene analysis in Sanmenxia City, Henan Province, China]., PMID:25868277
Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013., PMID:25754970
Development of a coxsackievirus A16 neutralization test based on the enzyme-linked immunospot assay., PMID:25704596
Expression of enterovirus 71 capsid protein VP1 in Escherichia coli and its clinical application., PMID:24688514
A new accurate assay for Coxsackievirus A 16 by fluorescence detection of isothermal RNA amplification., PMID:23872269
Specific primer amplification of the VP1 region directed by 5' UTR sequence analysis: enterovirus testing and identification in clinical samples from hand-foot-and-mouth disease patients., PMID:23769858
[Epidemiology and etiology of hand-foot-and-mouth disease in Hainan, 2010]., PMID:23757847
Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16., PMID:23499595
[Genetic characteristics of enterovirus 71 VP1 and epidemiology of hand-foot-mouth disease in Xinxiang in 2011]., PMID:23367569
Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein., PMID:23219932
Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71., PMID:22659489
Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011., PMID:22652041
A comparative study of the characteristics of two Coxsackie A virus type 16 strains (genotype B)., PMID:22566090
[A pathogen analysis within 174 cases of hand-foot-mouth disease in the summer of 2009]., PMID:22338230
Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection., PMID:22279543
Detection and characterization of enterovirus associated with herpangina and hand, foot, and mouth disease in Seoul, Korea., PMID:22239028
Comparing Enterovirus 71 with Coxsackievirus A16 by analyzing nucleotide sequences and antigenicity of recombinant proteins of VP1s and VP4s., PMID:22050722
[Genomic characteristics and recombination of enterovirus 71 strains isolated in Henan Province between 2008 and 2010]., PMID:21998954
Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008-2011., PMID:21898187
[Molecular epidemiology of human enterovirus 71 strains in Qingdao region, Shandong province, 2007 - 2009]., PMID:21569671
An outbreak of coxsackievirus A16 infection: comparison with other enteroviruses in a preschool in Taipei., PMID:20688286
[To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008]., PMID:20387478
Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007., PMID:19628900
Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection., PMID:10797379
Rapid subgrouping of nonpolio enterovirus associated with Aseptic Meningitis by RFLP (Restriction Fragment Length Polymorphism) assay., PMID:9666471
Structural proteins of hand, foot and mouth disease viruses., PMID:6246027
For research use only. Not for human or drug use.
